Efficacy of Peginterferon alfa-2b in Nucleoside Analogue Experienced Patients with Negative HBeAg and Low HBsAg: A Non-Randomized Clinical Trial

INTRODUCTION: Hepatitis B surface antigen (HBsAg) clearance is the treatment goal for hepatitis B e antigen (HBeAg)-negative patients with chronic hepatitis B (CHB). However, its rate is extremely low with nucleoside (acid) analogues (NAs) monotherapy. Peginterferon could enhance HBsAg clearance. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun, Qi, Min, Fan, Xue-Gong, Hu, Xing-Wang, Liao, Cheng-Jin, Long, Li-Yuan, Zhao, Xiao-Ting, Tan, Min, Li, Hai-Fu, Chen, Ruo-Chan, Huang, Ze-Bing, Huang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572941/
https://www.ncbi.nlm.nih.gov/pubmed/34309813
http://dx.doi.org/10.1007/s40121-021-00497-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572941/
https://www.ncbi.nlm.nih.gov/pubmed/34309813
http://dx.doi.org/10.1007/s40121-021-00497-5

Ejemplares similares